Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

anti-IgG1 κ, Hamster, Clone: A19-3, Isotype Control, BD

Catalog No. BDB553969 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.5 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB553969 0.5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB553969 Supplier BD Biosciences Supplier No. 553969
Add to Cart
Add to Cart

The A19-3 clone reacts with the hapten, trinitrophenol (TNP). TNP is not expressed on human, mouse, or rat cells. The immunoglobulin from clone A19-3 was selected as an isotype control following screening for low background on a variety of mouse and human tissues. This antibody is routinely tested by immunohistochemistry. Other applications were tested at BD Biosciences Pharmingen during antibody development only or reported in the literature.

Host Species: Hamster
Clone: A19-3
Isotype: IgG1, κ
Immunogen: TNP-keyhole limpet hemocyanin

Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Immunohistochemistry (Zinc-Fixed)

TRUSTED_SUSTAINABILITY

Specifications

Applications ELISA, Immunohistochemistry
Clone A19-3
Concentration 0.5mg/mL
Conjugate Unconjugated
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Host Species Hamster
Immunogen TNP-keyhole limpet hemocyanin
Purification Method Affinity Purified
Quantity 0.5 mg
Content And Storage Undiluted at 4°C
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.